ETTX Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 июнь 2024 @ 23:00):

Stats
Объем за сегодня	68 834
Средний объем	0
Рыночная капитализация	0.00
EPS	$-0.320 ( Q1 \| 2022-04-27 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.950 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0320 (1.46%)

AADI -6.18%

ABCL 2.20%

ABCM 0.04%

ABEO -3.55%

ABIO -1.68%

ABOS 5.14%

ABSI 4.08%

ABUS -0.82%

ABVX -1.88%

ACAD 0.00%

ACER -17.95%

ACET -8.53%

ACGN 1.29%

ACHL -2.48%

ACHV 3.89%

ACIU -1.00%

ACLX 0.09%

ACRV -5.61%

ACST -4.89%

ACXP 3.92%

ADAG 6.07%

ADAP -2.94%

ADGI 0.87%

ADIL -1.70%

ADMA -1.77%

ADPT 0.74%

ADTX -2.78%

ADVM 1.45%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -1.57%

AGEN -3.29%

AGIO -1.90%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 5.18%

AKRO -2.45%

AKTX -2.38%

AKUS 0.00%

ALBO 0.00%

ALDX -1.80%

ALEC 0.00%

ALGS 1.32%

ALKS 1.82%

ALLK -11.44%

ALLO -4.17%

ALLR -2.92%

ALNA 3.16%

ALNY 2.19%

ALPN 0.02%

ALPX 0.00%

ALRN -2.24%

ALT -13.93%

ALVR -0.69%

ALXN 0.00%

ALXO -13.70%

ALZN 4.02%

AMRN -2.50%

AMTI -3.13%

ANAB 1.64%

ANEB 6.06%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 2.51%

ANPC -3.15%

APGE 0.75%

APGN 8.48%

APGNW 30.65%

APLM -5.90%

APLS 1.06%

APLT -0.68%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 2.04%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -5.66%

ARDS -12.13%

ARDX 0.85%

ARGX -0.49%

ARNA 0.00%

ARPO -0.90%

ARQT -2.50%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.73%

ARWR -1.64%

ASLN -3.43%

ASMB -4.22%

ASND -2.03%

ATAI -3.33%

ATHA 6.86%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 5.37%

ATRA -3.60%

ATXI 2.70%

ATXS -0.22%

AUPH -0.99%

AURA 4.55%

AUTL -3.02%

AVBP -3.26%

AVEO 0.00%

AVIR -2.19%

AVRO -1.41%

AVTE 0.34%

AVTX -3.74%

AVXL -4.82%

AXLA 0.00%

AXSM -1.29%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.16%

BCAB -3.01%

BCDA -3.75%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.21%

BCRX 1.97%

BCTX 8.16%

BCTXW 13.02%

BCYC 0.95%

BDRX -4.09%

BDTX 0.23%

BEAM 2.64%

BFRA -2.91%

BGNE -2.02%

BIOR -5.27%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.47%

BLTE -1.03%

BLU 0.03%

BLUE -1.97%

BMEA -13.82%

BMRN 0.53%

BNOX 6.15%

BNTC -1.69%

BNTX -1.74%

BOLD -7.90%

BOLT -0.05%

BPMC -1.40%

BPTH -1.90%

BPTS -13.47%

BRNS -0.37%

BRTX -6.13%

BTAI 12.71%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.36%

CABA 1.66%

CADL 0.53%

CALA 0.00%

CALC -9.65%

CALT -1.59%

CAPR -1.08%

CARA -3.29%

CARM 6.96%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.86%

CCXI 0.00%

CDAK 0.00%

CDIO -5.08%

CDIOW 24.00%

CDMO -1.55%

CDMOP 0.04%

CDT -2.44%

CDTTW -39.60%

CDTX -6.44%

CDXC 7.79%

CDXS 9.31%

CELC -3.15%

CELU 2.67%

CELUW 11.80%

CERC -1.68%

CERE -1.52%

CERO -6.73%

CEROW -10.18%

CFRX -27.95%

CGEM 0.30%

CGEN -3.31%

CGON -1.53%

CGTX -4.35%

CHMA -6.00%

CHRS 4.13%

CINC 0.00%

CING -2.56%

CINGW 34.95%

CKPT -1.91%

CLBS -16.75%

CLDX -0.55%

CLGN -0.20%

CLLS -3.13%

CLNN -2.72%

CLNNW 0.00%

CLRB 7.06%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 5.65%

CMPI 0.00%

CMPX 0.00%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.54%

CNCE 0.00%

CNSP -36.15%

CNST 0.00%

CNTA 0.00%

CNTB -0.75%

CNTX -4.79%

COCP -2.00%

COEPW 32.45%

COGT -2.16%

CORT 2.53%

COYA -0.65%

CPRX -1.72%

CRBP -0.43%

CRBU -6.82%

CRDF 1.77%

CRGX 0.10%

CRIS -1.59%

CRNX -5.96%

CRSP -0.10%

CRTX 2.63%

CRVO -2.33%

CRVS 0.56%

CSBR -0.19%

CTCX -1.59%

CTIC 0.06%

CTMX -2.89%

CTNM 1.98%

CTXR -1.31%

CUE -1.73%

CVAC -7.20%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.44%

CYTO 0.00%

DARE 3.54%

DAWN -0.82%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 27.08%

DNLI -1.74%

DNTH -4.87%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL -0.24%

DYAI 9.68%

EARS -1.77%

EDIT -2.72%

EDSA 4.09%

EFTR 5.36%

EFTRW -53.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.65%

ELEV -1.24%

ELOX 10.77%

ELTX -5.15%

ELVN -1.82%

ELYM 4.60%

ENGN 0.86%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA 0.08%

ENTO -4.97%

ENTX -0.53%

ENVB 8.03%

EPIX -0.72%

EPRX -1.92%

EPZM 0.00%

EQ -0.90%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.24%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -4.01%

ETON 3.35%

ETTX 0.00%

EVAX -0.71%

EVGN 4.76%

EVLO 0.00%

EWTX -1.21%

EXAI -0.19%

EXEL 0.47%

EYEG -0.69%

EYEN 0.23%

EYPT 1.69%

FATE -11.42%

FBIO 0.86%

FBIOP 0.87%

FBLG -7.30%

FBRX -0.02%

FDMT -4.99%

FENC -2.26%

FGEN -10.21%

FHTX 8.21%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.37%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 1.16%

FULC 1.84%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.43%

GANX -2.31%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.43%

GHRS -3.72%

GLMD -4.09%

GLPG -1.56%

GLSI 5.01%

GLTO -3.31%

GLUE -3.43%

GLYC -11.51%

GMAB -0.35%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.60%

GNLX -4.42%

GNPX -2.46%

GNTA 3.94%

GOSS -10.88%

GOVX -2.73%

GOVXW 10.89%

GPCR -6.01%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.01%

GRTX -1.66%

GTHX 1.36%

GUTS 2.77%

GXGXW 41.67%

GYRE -4.54%

HALO -1.64%

HARP 0.09%

HCWB -6.13%

HEPA -3.64%

HGEN -84.62%

HILS 5.66%

HLVX -1.34%

HOOK 0.89%

HOTH -1.10%

HOWL 2.10%

HRMY 5.05%

HRTX 8.84%

HSTO 0.00%

HUMA 1.52%

HUMAW -6.26%

IBRX -5.50%

ICCC -4.42%

ICPT 0.21%

ICU 15.41%

ICUCW 9.30%

ICVX -0.91%

IDRA -23.04%

IDYA -3.16%

IFRX -2.78%

IGMS -1.02%

IKNA -0.30%

IKT -9.93%

IMAB -0.29%

IMCR -3.39%

IMGN 0.02%

IMGO 0.00%

IMMP 4.75%

IMMX -6.93%

IMNM 4.25%

IMNN 0.89%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -1.00%

IMTXW 6.00%

IMUX 2.78%

IMV 0.00%

IMVT -3.26%

INAB -1.68%

INBX -2.58%

INCY -2.36%

INDP 7.34%

INFI -52.38%

INKT 2.10%

INM 3.22%

INMB 4.90%

INO 2.08%

INSM -0.98%

INTS -1.96%

INVA 0.29%

INZY 2.29%

IOBT -10.94%

IONS 1.50%

IOVA -2.37%

IPA 3.00%

IPHA 3.05%

IPSC -2.34%

IRON -2.68%

ISEE 0.38%

ITOS 1.57%

ITRM 2.33%

IVA 6.96%

IVVD 0.00%

JAGX 1.57%

JANX -4.56%

JAZZ -0.82%

JNCE 0.00%

JSPR -1.91%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -3.99%

KDNY 0.22%

KMPH -0.34%

KNSA -1.85%

KNTE -0.38%

KOD -7.51%

KPRX -3.60%

KPTI -9.43%

KRBP -10.00%

KRON 1.68%

KROS -0.41%

KRRO -2.30%

KRTX 0.03%

KRYS 0.27%

KTRA 12.27%

KTTA -0.65%

KTTAW 0.92%

KURA 0.54%

KYMR -2.79%

KYTX -3.60%

KZIA 4.41%

KZR -0.12%

LABP 0.57%

LBPH -0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 0.97%

LENZ -1.92%

LEXX -1.54%

LEXXW -14.63%

LGND -1.01%

LGNDV 0.00%

LGVN -9.31%

LIAN -8.28%

LIFE 2.70%

LIPO -5.28%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -3.68%

LPTX -2.75%

LQDA 0.41%

LRMR 0.50%

LSTA -1.68%

LTRN 6.48%

LUMO 1.79%

LVTX -4.12%

LXEO -8.77%

LXRX -2.35%

LYEL -35.54%

LYRA 1.94%

MACK 0.10%

MBIO -11.56%

MBRX -1.43%

MCRB 2.60%

MDGL -2.34%

MDNA -13.16%

MDWD 3.56%

MDXG -2.06%

MEIP 0.00%

MESO -1.63%

MGNX -4.55%

MGTA -7.74%

MGTX -0.95%

MGX 2.41%

MIRM 0.45%

MIRO 0.59%

MIST 2.69%

MITO 0.00%

MLEC -7.68%

MLECW 2.31%

MLND -5.36%

MLTX 0.10%

MLYS -6.00%

MNKD -0.67%

MNMD 4.38%

MNOV -1.06%

MNPR -8.54%

MOLN 2.20%

MOR 0.45%

MORF -3.58%

MREO -2.00%

MRKR -0.43%

MRNA -9.32%

MRNS -5.51%

MRSN -2.85%

MRTX -0.17%

MRUS -0.58%

MRVI -0.44%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.33%

MYMD 1.08%

NAMS 0.35%

NAMSW -0.21%

NAUT 1.11%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.37%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.70%

NKGN 9.91%

NKGNW -18.03%

NKTR 4.21%

NKTX -4.00%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.09%

NMTR -42.97%

NOVN -24.84%

NRBO 16.39%

NRIX -0.39%

NRSN -4.82%

NRSNW 0.00%

NRXP -9.17%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -5.21%

NTRBW -31.07%

NUVL -0.98%

NVAX -7.57%

NVCT -7.75%

NVIV -34.28%

NXTC -3.53%

NYMX -0.05%

OABI 3.17%

OABIW -10.06%

OBIO -1.17%

OBSV 0.00%

OCEA -2.11%

OCGN 8.05%

OCS -1.00%

OCUL 1.14%

OCUP 1.32%

ODT -4.27%

OKYO 2.15%

OLMA -4.77%

OMER -2.31%

OMGA 0.42%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 2.97%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT -2.58%

ORGS -0.69%

ORIC -1.19%

ORMP 18.31%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.66%

OVID 0.01%

OYST 0.00%

PALI -0.22%

PASG 2.63%

PBLA -7.50%

PBM -2.18%

PBYI 2.70%

PCSA -1.93%

PCVX 0.05%

PDSB -6.65%

PEPG 1.19%

PGEN -5.99%

PHAR 2.19%

PHAS 0.00%

PHAT -0.44%

PHIO -3.55%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.02%

PLUR 7.39%

PMN -5.55%

PMVP -2.08%

PNT 0.16%

PPBT -6.43%

PRAX 7.07%

PRDS 0.93%

PRLD -2.64%

PROG -3.47%

PROK -0.45%

PRQR 1.18%

PRTA -2.72%

PRTC 0.62%

PRTG 1.00%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -14.04%

PSTX -2.71%

PTCT -0.63%

PTE -0.82%

PTGX -1.13%

PTIXW -48.41%

PULM 1.53%

PXMD 4.76%

PYPD 1.71%

PYXS 3.91%

QLGN -7.22%

QNCX 5.70%

QNRX -0.15%

QSI -35.63%

QSIAW -3.13%

QTTB 1.83%

QURE -0.90%

RAIN -1.63%

RANI 4.81%

RAPT -1.62%

RARE 1.91%

RCKT -9.64%

REGN -0.24%

RENB -2.78%

REPL -1.25%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -5.96%

RGNX -6.58%

RIGL -6.25%

RLAY -4.60%

RLMD 0.00%

RLYB -4.03%

RNA 1.95%

RNAC -4.70%

RNAZ 0.00%

RNXT 1.79%

ROIV -1.71%

ROIVW 4.56%

RPHM -1.39%

RPRX -0.59%

RPTX -0.59%

RUBY 2.70%

RVLP -32.05%

RVMD -0.54%

RVMDW -29.90%

RVNC 0.21%

RVPH -0.79%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.70%

RYTM -5.87%

RYZB 0.02%

RZLT 3.50%

SABS -1.37%

SABSW -11.81%

SAGE 0.64%

SANA -2.58%

SAVA -1.48%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.59%

SCPH 10.61%

SCPS 0.00%

SEEL -3.51%

SEER 0.30%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.39%

SGMT -5.30%

SGTX -2.56%

SIOX 22.63%

SLDB -3.97%

SLGL 5.23%

SLN -6.37%

SLNO 0.77%

SLRX 1.21%

SLS -2.56%

SMMT -3.25%

SNDX 3.28%

SNGX -0.38%

SNPX -2.55%

SONN -2.13%

SPPI -0.49%

SPRB -1.38%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.17%

SRRA 0.00%

SRRK -1.61%

SRZN -2.45%

STAB 0.00%

STOK -6.81%

STRO -1.50%

STSA 0.00%

STTK 6.91%

SURF -0.93%

SVRA -0.29%

SWTX 0.25%

SYBX 1.29%

SYRS -1.72%

TALS -0.73%

TARA -7.38%

TARS -2.01%

TBPH 0.71%

TCBP 6.94%

TCDA 0.00%

TCON -0.34%

TCRR 0.00%

TCRT -1.75%

TCRX 4.85%

TECH -0.85%

TENX -0.32%

TERN -8.42%

TFFP -7.61%

TGTX -6.98%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -7.23%

TNGX -3.40%

TNXP -6.80%

TNYA -3.68%

TPST 6.21%

TRDA -4.67%

TRVI 3.07%

TRVN 3.11%

TSHA -19.07%

TSVT -3.99%

TTNP -6.05%

TVTX 3.14%

TYRA -6.95%

UBX -2.55%

UNCY -4.44%

URGN 2.73%

UTHR -0.10%

VACC 11.36%

VALN -6.70%

VAXX 94.50%

VBIV 0.93%

VBLT -8.77%

VCEL 0.94%

VCNX 9.03%

VCYT -0.84%

VERA -5.51%

VERU 3.02%

VERV -2.29%

VIGL -1.88%

VINC 2.93%

VIR -0.87%

VIRI -5.72%

VIRX 3.98%

VKTX -1.67%

VLON -13.04%

VNDA -3.94%

VOR -6.05%

VRCA 0.36%

VRDN -3.61%

VRNA -1.60%

VRPX 1.02%

VRTX 0.09%

VSTM 3.91%

VTGN -1.51%

VTVT 0.39%

VTYX -2.55%

VXRT -1.92%

VYGR -0.64%

VYNE -5.20%

VYNT 7.78%

WINT -0.60%

WVE -8.50%

XBIO 1.03%

XBIT 7.50%

XCUR 3.77%

XENE -2.03%

XERS 5.00%

XFOR 5.21%

XLO 4.42%

XLRN 0.00%

XNCR 0.47%

XOMA -10.03%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.39%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.46%

ZNTL -1.07%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-07-08	Innoviva Strategic Opportunities Llc	Buy	7 598 814	Common Stock
2022-07-07	Tommasi Ruben	Sell	39 596	Common Stock
2022-07-11	Tommasi Ruben	Sell	150 000	Common Stock
2022-07-11	Tommasi Ruben	Sell	98 700	Stock Option (right to buy)
2022-07-11	Tommasi Ruben	Sell	50 000	Stock Option (right to buy)

INSIDER POWER
52.71
Last 98 transactions
Buy: 9 607 238 \| Sell: 3 128 729

Объем Корреляция

Длинно: 0.20 (neutral)

Кратко: -0.50 (neutral)

Signal:(62.724) Neutral

Entasis Therapeutics Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Entasis Therapeutics Корреляция - Валюта/Сырье

0.33
( neutral )

-0.29
( neutral )

0.00
( neutral )

0.38
( neutral )

0.00
( neutral )

-0.69
( moderate negative )

Entasis Therapeutics Финансовые показатели

Annual	2021
Выручка:	$0.00
Валовая прибыль:	$0.00 (0.00 %)
EPS:	$-0.996

FY	2021
Выручка:	$0.00
Валовая прибыль:	$0.00 (0.00 %)
EPS:	$-0.996

FY	2020
Выручка:	$0.00
Валовая прибыль:	$0.00 (0.00 %)
EPS:	$-2.10

FY	2019
Выручка:	$7.00M
Валовая прибыль:	$0.00 (0.00 %)
EPS:	$-3.33

Financial Reports:

No articles found.

Entasis Therapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Entasis Therapeutics

Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibacterial products to treat serious infections caused by multidrug-resistant pathogens in the United States. Its lead product candidate is sulbactam-durlobactam (SUL-DUR), a novel IV antibiotic that is in Phase III clinical trial for the treatment of pneumonia and bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii. The company also develops Zoliflodacin, a novel orally administered molecule, which is in Phase III clinical trial for the treatment of uncomplicated gonorrhea; ETX0282CPDP, an oral drug that is in Phase I clinical trial for the treatment of urinary tract infections; and ETX0462, a drug candidate from NBP platform that is in pre-clinical stage for the treatment of multidrug-resistant gram-negative infections. The company has a license and collaboration agreement with Zai Lab (Shanghai) Co., Ltd. for the development of durlobactam and SUL-DUR; and collaboration agreement with Global Antibiotic Research and Development Partnership for the development and commercialization of a product candidate zoliflodacin. Entasis Therapeutics Holdings Inc. was founded in 2015 and is headquartered in Waltham, Massachusetts. Entasis Therapeutics Holdings Inc. operates as a subsidiary of Innoviva, Inc.